Evaluating the real-life effect of MP-AzeFlu on asthma outcomes in patients with allergic rhinitis and asthma in UK primary care

BACKGROUND: MP-AzeFlu (Dymista®; spray of azelastine/fluticasone propionate) is the most effective allergic rhinitis (AR) treatment available. Its effect on asthma outcomes in patients with AR and asthma is unknown. METHODS: This pre-post historical cohort study, using the Optimum Patient Care Resea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World Allergy Organ J
Main Authors: De Jong, Hilda J.I., Voorham, Jaco, Scadding, Glenis K., Bachert, Claus, Canonica, Giorgio Walter, Smith, Peter, Wahn, Ulrich, Ryan, Dermot, Castillo, Jose A., Carter, Victoria A., Murray, Ruth B., Price, David B.
Formato: Artigo
Idioma:Inglês
Publicado em: World Allergy Organization 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7753940/
https://ncbi.nlm.nih.gov/pubmed/33376573
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.waojou.2020.100490
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados